Expression of p27 is associated with Bax expression and spontaneous apoptosis in oral and oropharyngeal carcinoma

Citation
S. Fujieda et al., Expression of p27 is associated with Bax expression and spontaneous apoptosis in oral and oropharyngeal carcinoma, INT J CANC, 84(3), 1999, pp. 315-320
Citations number
26
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF CANCER
ISSN journal
00207136 → ACNP
Volume
84
Issue
3
Year of publication
1999
Pages
315 - 320
Database
ISI
SICI code
0020-7136(19990621)84:3<315:EOPIAW>2.0.ZU;2-X
Abstract
p27(Kipl), a cyclin-dependent kinase inhibitor, is a negative regulator of the cell cycle, and apoptosis is a genetically encoded program of cell deat h. To clarify the relationship, between the cell cycle and apoptosis, we in vestigated expression of p27, cyclin DI and apoptosis-related proteins (p53 , Bar, Bcl-2 and c-Myc) in 60 cases of oral and oropharyngeal squamous-cell carcinoma (SCC) using an immuno-histochemical approach, and evaluated spon taneous apoptosis in vivo. Our most notable finding was that spontaneous ap optosis in the p27-positive group was significantly higher than that in the p27-negative group (p = 0.028). In addition, the percentage of p27-positiv e cells was clearly correlated with that of Bar-positive cells (gamma = 0.2 88, p = 0.028) and with that of cyclin DI-positive cells (gamma = 0.416, p = 0.002). Expression of p27 was inversely associated with the clinical stag e of total tumor progression (p = 0.027). However, no correlation was found between p27 expression and the following parameters: gender, tumor size, l ymph node metastasis, overall survival and disease-free survival. Our resul ts give evidence that the action of the cell-cycle regulator p27 is closely linked with apoptosis in clinical samples from patients and indicate that over-expression of p27 might induce apoptosis in cancer cells through eleva tion of Bar expression, thereby acting on tumor progression. Int. J. Cancer (Pred. Oncol.) 84:315-320, 1999. (C) 1999 Wiley-Liss, Inc.